- To determine the best outcome measures to accelerate evaluation of emerging treatments.
- To better understand disease progression for selecting future clinical trial participants.
- To identify potential participants for forthcoming clinical trials.
- To establish technology, trial sites, Reading Center, and patient cohorts.